Chronic hypoxaemia and gender status modulate adiponectin plasmatic level and its multimer proportion in severe COPD patients: new endotypic presentation?
Abstract Background Disease progression in COPD patient is associated to lung function decline, leading to a higher risk of hypoxaemia and associated comorbidities, notably cardiovascular diseases (CVD). Adiponectin (Ad) is an adipokine with cardio-protective properties. In COPD patients, conflictin...
| Published in: | BMC Pulmonary Medicine |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-10-01
|
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s12890-020-01288-3 |
